Rilmakalim

CAS No. 132014-21-2

Rilmakalim( —— )

Catalog No. M34129 CAS No. 132014-21-2

Rilmakalim is a potassium channel opener. Rilmakalim shows antivasoconstrictor effect.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 198 Get Quote
5MG 304 Get Quote
10MG 456 Get Quote
25MG 723 Get Quote
50MG 994 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Rilmakalim
  • Note
    Research use only, not for human use.
  • Brief Description
    Rilmakalim is a potassium channel opener. Rilmakalim shows antivasoconstrictor effect.
  • Description
    Rilmakalim (HOE 234) is a potassium channel opener(PCO) that activates ATP-sensitive K+ channels in theheart or other tissues.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Sodium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    132014-21-2
  • Formula Weight
    401.48
  • Molecular Formula
    C21H23NO5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O[C@H]1[C@@H](C=2C(=CC=C(S(=O)(=O)C3=CC=CC=C3)C2)OC1(C)C)N4C(=O)CCC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kocic, Ivanet al. Hypotonic stress increases efficacy of rilmakalim, but not pinacidil, toactivate ATP-sensitive K(+) current in guinea pig ventricular myocytes. Journalof pharmacological sciences vol. 95,2 (2004): 189-95.?
molnova catalog
related products
  • PF-04885614

    PF-04885614 is a potent inhibitor of NaV1.8, has potential for neurological and neurodevelopmental diseases treatment.

  • ProTx II

    Selective NaV1.7 channel blocker. Shifts activation gating positively and decreases current magnitude. Displays 100-fold selectivity over other sodium channel subtypes.

  • Ralitoline

    Ralitoline (Ralitolinum) is an anticonvulsant with anticancer activity and sodium channel blocking activity.